Autopsy report · NCT00760604

A Phase III Study of En Bloc Versus Non-En Bloc Esophagectomy in Esophageal Cancer

“Closed due to slow patient accrual.”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 3 years 7 months before it stopped.
• 4 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 3

Sponsor

Weill Medical College of Cornell University

Sponsor type

University, hospital or other

Conditions

Esophageal Neoplasms

Interventions

Esophagectomy

Participants

4

Sites

1

Countries

United States

Trials that died the same way

• Combination Veltuzumab and Fractionated 90Y- Epratuzumab Radioimmunotherapy in Follicular Lymphoma
  “closed to enrollment due to slow patient accrual” (74% match in meaning)
• Effects of Methylphenidate Versus Sustained Release Methylphenidate on Cognitive Functioning
  “Closed early due to slow accrual.” (74% match in meaning)
• Use of Rituximab in Opsoclonus-Myoclonus in Children With Neuroblastoma
  “Closed early due to low accrual.” (73% match in meaning)
• Study of Pegylated Interferon-Alfa 2b in Combination With PUVA Therapy In CTCL
  “Closed early due to poor accrual.” (71% match in meaning)
• Bortezomib, Arsenic Trioxide, and Melphalan in Treating Patients Undergoing an Autologous Stem Cell Transplant For Multiple Myeloma
  “Temporarily closed to accrual pending availablity of drug.” (70% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.